Patents by Inventor Maria Rosa Sarrias Fornés

Maria Rosa Sarrias Fornés has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD5L antibody and uses thereof
    Patent number: 11370844
    Abstract: The invention relates to a CD5L-binding agent or a pharmaceutical composition thereof for use in the treatment of cancer by inhibiting macrophage M2 activation or promoting lymphocyte activation.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: June 28, 2022
    Assignee: FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS I PUJOL
    Inventors: Maria Rosa Sarrias Fornés, Lucía Sanjurjo Bouza, Gemma Aran Canals
  • ANTI-CD5L ANTIBODY AND USES THEREOF
    Publication number: 20200354467
    Abstract: The invention relates to a CD5L-binding agent or a pharmaceutical composition thereof for use in the treatment of cancer by inhibiting macrophage M2 activation or promoting lymphocyte activation.
    Type: Application
    Filed: October 30, 2018
    Publication date: November 12, 2020
    Inventors: Maria Rosa SARRIAS FORNÉS, Lucía SANJURJO BOUZA, Gemma ARAN CANALS
  • Protein product for treatment of infectious diseases and related inflammatory processes
    Patent number: 8691752
    Abstract: The inventors have found that CD6, a member of the Scavenger Receptor Cysteine-Rich (SRSR) superfamily expressed on human lymphocytes binds to Gram-positive and Gram-negative bacteria, as well as to other microbial structures. Thus, a CD6 product is useful for the manufacture of a medicament for therapeutic and/or preventive treatment of an infectious disease or of an inflammatory condition related to an infectious disease or to the presence of a product derived from an infectious agent in a mammal including a human. Examples of such inflammatory conditions are systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: April 8, 2014
    Assignee: Universidad de Barcelona
    Inventors: Maria Rosa Sarrias Fornés, Francisco Lozano Soto
  • Protein Product for Treatment of Infectious Diseases and Related Inflammatory Processes
    Publication number: 20100105622
    Abstract: The inventors have found that CD6, a member of the Scavenger Receptor Cysteine-Rich (SRSR) superfamily expressed on human lymphocytes binds to Gram-positive and Gram-negative bacteria, as well as to other microbial structures. Thus, a CD6 product is useful for the manufacture of a medicament for therapeutic and/or preventive treatment of an infectious disease or of an inflammatory condition related to an infectious disease or to the presence of a product derived from an infectious agent in a mammal including a human. Examples of such inflammatory conditions are systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock.
    Type: Application
    Filed: March 27, 2008
    Publication date: April 29, 2010
    Applicant: Universidad de Barcelona
    Inventors: Maria Rosa Sarrias Fornés, Francisco Lozano Soto